Background/Aims: The Alzheimer drug memantine (1-amino-3,5-dimethyl-adamantane) blocks the pore channel of the NMDA receptor. Since memantine also blocks the 5-HT3 receptor, neuronal nicotinic receptor, and voltage-activated Na+ channels, the purpose of our study was to verify whether memantine could influence other types of channels involved in the regulation of Ca2+. Methods: Free intracellular Ca2+ concentrations in whole cells and in saponin-permeabilized cells were monitored spectrofluorometrically in HEK-293 cells stably expressing TRPC6. Results: Memantine decreased the basal level of intracellular Ca2+, increased the content of the intracellular Ca2+ store, which in turn increased the agonist-induced intracellular Ca2+ release, and increased the store-operated Ca2+ entry. Conclusion: In addition to blocking the NMDA receptor, memantine also decreases the basal level of intracellular Ca2+ and increases the sensitivity of cells to extracellular stimuli. All these effects may be of benefit in the treatment of Alzheimer''s disease.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.